Cargando…

FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs/ERKs and PI3K/AKT Signaling Pathway

Breast cancer is a widespread and complex disease characterized by abnormal signaling pathways that promote tumor growth and progression. Despite significant medical advances and the development of increasingly effective therapies for breast cancer, drug resistance and reduced sensitivity to prior t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymczyk, Jakub, Czyrek, Aleksandra, Otlewski, Jacek, Zakrzewska, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376943/ https://www.ncbi.nlm.nih.gov/pubmed/37509496 http://dx.doi.org/10.3390/biomedicines11071856

Ejemplares similares

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
por: Szymczyk, Jakub, et al.
Publicado: (2022)

Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity
por: Szlachcic, Anna, et al.
Publicado: (2019)

Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells
por: Lampart, Agata, et al.
Publicado: (2022)

FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner
por: Sochacka, Martyna, et al.
Publicado: (2020)

FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Szymczyk, Jakub, et al.
Publicado: (2021)

Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling
por: Zakrzewska, Malgorzata, et al.
Publicado: (2019)

Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
por: Gedaj, Aleksandra, et al.
Publicado: (2023)

Intracellular FGF1 protects cells from apoptosis through direct interaction with p53
por: Lampart, Agata, et al.
Publicado: (2023)

FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
por: Sochacka, Martyna, et al.
Publicado: (2022)

Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection
por: Lipok, Magdalena, et al.
Publicado: (2019)

Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins
por: Latko, Marta, et al.
Publicado: (2019)

FGF2 Dual Warhead Conjugate with Monomethyl Auristatin E and α-Amanitin Displays a Cytotoxic Effect towards Cancer Cells Overproducing FGF Receptor 1
por: Świderska, Karolina Weronika, et al.
Publicado: (2018)

Conceptual DFT as a chemoinformatics tool for the study of the Taltobulin anticancer peptide
por: Flores-Holguín, Norma, et al.
Publicado: (2019)

Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
por: Jendryczko, Karolina, et al.
Publicado: (2021)

Identification of new FGF1 binding partners—Implications for its intracellular function
por: Bober, Joanna, et al.
Publicado: (2016)

High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1
por: Opaliński, Łukasz, et al.
Publicado: (2018)

Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin
por: Zakrzewska, Malgorzata, et al.
Publicado: (2009)

Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1)
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2020)

Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
por: Zukowska, Dominika, et al.
Publicado: (2023)

Correction: Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
por: Gedaj, Aleksandra, et al.
Publicado: (2023)

Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2017)

FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation
por: Szlachcic, Anna, et al.
Publicado: (2012)

Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
por: Chudzian, Julia, et al.
Publicado: (2018)

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
por: Gregorczyk, Paulina, et al.
Publicado: (2023)

FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
por: Pozniak, Marta, et al.
Publicado: (2020)

The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells
por: Poźniak, Marta, et al.
Publicado: (2021)

Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021)

Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway
por: Ramakrishnan, Vijay, et al.
Publicado: (2012)

FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
por: Poźniak, Marta, et al.
Publicado: (2021)

Nucleolin Regulates Phosphorylation and Nuclear Export of Fibroblast Growth Factor 1 (FGF1)
por: Sletten, Torunn, et al.
Publicado: (2014)

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
por: Li, Qingfang, et al.
Publicado: (2022)

RNA sequencing analysis to demonstrate Erk dependent and independent functions of Mek
por: Liu, Chang, et al.
Publicado: (2015)

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
por: Yajima, Ichiro, et al.
Publicado: (2012)

Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity
por: Opaliński, Łukasz, et al.
Publicado: (2017)

Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation
por: Gündüz, Dursun, et al.
Publicado: (2019)

Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis
por: Muranushi, Hiroyuki, et al.
Publicado: (2022)

Galangin ameliorates cardiac remodeling via the MEK1/2–ERK1/2 and PI3K–AKT pathways
por: Wang, Hui‐Bo, et al.
Publicado: (2019)

HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
por: Li, Qing, et al.
Publicado: (2018)

Caulis Polygoni Multiflori Accelerates Megakaryopoiesis and Thrombopoiesis via Activating PI3K/Akt and MEK/ERK Signaling Pathways
por: Yang, Xin, et al.
Publicado: (2022)

PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways
por: Fu, Xueqiong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uup33m9sof7ic8bfj7ctm4pjrl